8.05
price up icon0.12%   0.01
pre-market  Pre-mercato:  8.19   0.14   +1.74%
loading
Precedente Chiudi:
$8.04
Aprire:
$8.01
Volume 24 ore:
1.62M
Relative Volume:
1.21
Capitalizzazione di mercato:
$1.11B
Reddito:
$175.51M
Utile/perdita netta:
$-78.02M
Rapporto P/E:
-15.19
EPS:
-0.53
Flusso di cassa netto:
$-34.18M
1 W Prestazione:
-7.15%
1M Prestazione:
+1.26%
6M Prestazione:
+10.88%
1 anno Prestazione:
+49.07%
Intervallo 1D:
Value
$7.975
$8.225
Intervallo di 1 settimana:
Value
$7.93
$8.73
Portata 52W:
Value
$4.71
$10.67

Aurinia Pharmaceuticals Inc Stock (AUPH) Company Profile

Name
Nome
Aurinia Pharmaceuticals Inc
Name
Telefono
250-744-2487
Name
Indirizzo
#140, 14315 - 118 AVENUE, EDMONTON, BC
Name
Dipendente
300
Name
Cinguettio
@AuriniaPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
AUPH's Discussions on Twitter

Confronta AUPH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
AUPH
Aurinia Pharmaceuticals Inc
8.05 1.11B 175.51M -78.02M -34.18M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Aurinia Pharmaceuticals Inc Stock (AUPH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-04 Downgrade Oppenheimer Outperform → Perform
2022-05-05 Ripresa Cantor Fitzgerald Overweight
2021-12-10 Aggiornamento Oppenheimer Perform → Outperform
2021-10-28 Downgrade Oppenheimer Outperform → Perform
2021-01-25 Reiterato H.C. Wainwright Buy
2020-11-03 Reiterato H.C. Wainwright Buy
2020-06-17 Iniziato BTIG Research Buy
2020-05-05 Iniziato Cowen Outperform
2020-01-10 Iniziato Jefferies Buy
2019-12-16 Reiterato H.C. Wainwright Buy
2018-03-16 Reiterato Cantor Fitzgerald Overweight
2018-02-08 Iniziato RBC Capital Mkts Outperform
2017-10-30 Reiterato H.C. Wainwright Buy
2017-05-18 Reiterato H.C. Wainwright Buy
2017-04-11 Iniziato Cantor Fitzgerald Overweight
2017-03-22 Reiterato FBR & Co. Outperform
2016-12-30 Reiterato H.C. Wainwright Buy
2016-08-17 Reiterato H.C. Wainwright Buy
2016-06-30 Iniziato H.C. Wainwright Buy
2015-05-08 Iniziato MLV & Co Buy
Mostra tutto

Aurinia Pharmaceuticals Inc Borsa (AUPH) Ultime notizie

pulisher
Apr 01, 2025

Little Excitement Around Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) Revenues - simplywall.st

Apr 01, 2025
pulisher
Mar 25, 2025

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March - Insider Monkey

Mar 25, 2025
pulisher
Mar 25, 2025

(AUPH) Trading Signals - news.stocktradersdaily.com

Mar 25, 2025
pulisher
Mar 10, 2025

Aurinia Pharmaceuticals Announces Financial Growth and Pipeline Progress in 2024 - Zenopa

Mar 10, 2025
pulisher
Mar 09, 2025

Principal Financial Group Inc. Sells 1,325 Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Aurinia Pharmaceuticals Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 08, 2025

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome - MarketScreener

Mar 08, 2025
pulisher
Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Aurinia Pharmaceuticals’ chief medical officer sells shares worth $68,350 By Investing.com - Investing.com UK

Mar 07, 2025
pulisher
Mar 07, 2025

Commit To Purchase Aurinia Pharmaceuticals At $7, Earn 17.4% Annualized Using Options - Nasdaq

Mar 07, 2025
pulisher
Mar 06, 2025

Aurinia Pharmaceuticals' (NASDAQ:AUPH) Earnings May Just Be The Starting Point - Yahoo Finance

Mar 06, 2025
pulisher
Mar 05, 2025

Aurinia Pharmaceuticals stock climbs on insider buying - MSN

Mar 05, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CEO Peter Greenleaf sells shares worth $2.87 million - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals CFO Joseph Miller sells shares worth $939,611 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals’ chief medical officer sells $97,912 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals COO Donley sells shares worth $994,424 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Aurinia Pharmaceuticals EVP Stephen Robertson sells shares worth $975,223 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock? - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

Objective long/short (AUPH) Report - Stock Traders Daily

Mar 04, 2025
pulisher
Mar 03, 2025

LAWSUITS FILED AGAINST ABBV, SDIG and AUPHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Atria Wealth Solutions Inc. Buys Shares of 15,000 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - Defense World

Mar 03, 2025
pulisher
Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Simply Wall St

Mar 02, 2025
pulisher
Mar 02, 2025

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Canada Finance

Mar 02, 2025
pulisher
Feb 28, 2025

IFP Advisors Inc Raises Stock Position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals (NASDAQ:AUPH) Sees Strong Trading Volume Following Strong Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025
pulisher
Feb 28, 2025

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations - Benzinga

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia: Q4 Earnings Snapshot - CT Insider

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Aurinia Pharmaceuticals Q4 2024 misses EPS forecast - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises -February 27, 2025 at 09:26 am EST - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Strong Financial Growth in 2024 - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Files Form 8-K Indicating Key Corporate Event - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (AUPH) Aurinia Pharmaceuticals Reports Q4 Revenue $59.9M, vs. FactSet Est of $60.1M - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $0.01, vs. FactSet Est of $0.02 Loss - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Inc. SEC 10-K Report - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharma earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress - Business Wire

Feb 27, 2025
pulisher
Feb 25, 2025

High Growth Tech Stocks In The United States Spotlighting Three Leaders - Yahoo Finance

Feb 25, 2025
pulisher
Feb 25, 2025

Is Aurinia Pharmaceuticals Inc. (AUPH) the Best Small-Cap Growth Stock to Buy Now? - Insider Monkey

Feb 25, 2025

Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
Capitalizzazione:     |  Volume (24 ore):